Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121

1.

After the Loss of an Infant: Suppression of Breast Milk Supply.

Warr DL.

Neonatal Netw. 2019 Jul 1;38(4):226-228. doi: 10.1891/0730-0832.38.4.226. Epub 2019 Jul 8.

PMID:
31470391
2.

The Structure of VOPc on Cu(111): Does V=O Point Up, or Down, or Both?

Blowey PJ, Maurer RJ, Rochford LA, Duncan DA, Kang JH, Warr DA, Ramadan AJ, Lee TL, Thakur PK, Costantini G, Reuter K, Woodruff DP.

J Phys Chem C Nanomater Interfaces. 2019 Apr 4;123(13):8101-8111. doi: 10.1021/acs.jpcc.8b07530. Epub 2018 Oct 12.

3.

Quantity or quality? Assessing relationships between perceived social connectedness and recorded encounters.

Dias A, Geard N, Campbell PT, Warr D, McVernon J.

PLoS One. 2018 Nov 29;13(11):e0208083. doi: 10.1371/journal.pone.0208083. eCollection 2018.

4.

Re-evaluating how charge transfer modifies the conformation of adsorbed molecules.

Blowey PJ, Velari S, Rochford LA, Duncan DA, Warr DA, Lee TL, De Vita A, Costantini G, Woodruff DP.

Nanoscale. 2018 Aug 9;10(31):14984-14992. doi: 10.1039/c8nr02237b.

5.

Sequencing conjugated polymers by eye.

Warr DA, Perdigão LMA, Pinfold H, Blohm J, Stringer D, Leventis A, Bronstein H, Troisi A, Costantini G.

Sci Adv. 2018 Jun 15;4(6):eaas9543. doi: 10.1126/sciadv.aas9543. eCollection 2018 Jun.

6.

TCNQ Physisorption on the Topological Insulator Bi2 Se3.

Pia AD, Lisi S, Luca O, Warr DA, Lawrence J, Otrokov MM, Aliev ZS, Chulkov EV, Agostino RG, Arnau A, Papagno M, Costantini G.

Chemphyschem. 2018 Sep 18;19(18):2405-2410. doi: 10.1002/cphc.201800259. Epub 2018 Jun 19.

PMID:
29847012
7.

Should palonosetron be a preferred 5-HT3 receptor antagonist for chemotherapy-induced nausea and vomiting? An updated systematic review and meta-analysis.

Chow R, Warr DG, Navari RM, Tsao M, Popovic M, Chiu L, Milakovic M, Lam H, DeAngelis C.

Support Care Cancer. 2018 Aug;26(8):2519-2549. doi: 10.1007/s00520-018-4237-7. Epub 2018 May 23.

PMID:
29796708
8.

Bringing it all together in the treatment of CINV: application of current knowledge into routine clinical practice.

Warr D.

Support Care Cancer. 2018 Mar;26(Suppl 1):29-33. doi: 10.1007/s00520-018-4117-1. Epub 2018 Mar 19.

9.

Searching for perfection: further progress in management of chemotherapy-induced nausea and vomiting-CME information.

Aapro M, Clemons M, Schwartzberg L, Warr D.

Support Care Cancer. 2018 Mar;26(Suppl 1):1-2. doi: 10.1007/s00520-018-4122-4. Epub 2018 Mar 19. No abstract available.

PMID:
29556807
10.

Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancer.

Pezo RC, Chen TW, Berman HK, Mulligan AM, Razak AA, Siu LL, Cescon DW, Amir E, Elser C, Warr DG, Sridhar SS, Yu C, Wang L, Stockley TL, Kamel-Reid S, Bedard PL.

Breast Cancer Res Treat. 2018 Feb;168(1):159-168. doi: 10.1007/s10549-017-4580-2. Epub 2017 Nov 24.

11.

Do Correlates of Pain-Related Stoicism and Cautiousness Differ in Younger and Older People With Advanced Cancer?

Mah K, Tran KT, Gauthier LR, Rodin G, Zimmermann C, Warr D, Librach SL, Moore M, Shepherd FA, Gagliese L.

J Pain. 2018 Mar;19(3):301-316. doi: 10.1016/j.jpain.2017.11.002. Epub 2017 Nov 16.

PMID:
29155166
12.

Probing the interplay between geometric and electronic structure in a two-dimensional K-TCNQ charge transfer network.

Blowey PJ, Rochford LA, Duncan DA, Warr DA, Lee TL, Woodruff DP, Costantini G.

Faraday Discuss. 2017 Oct 26;204:97-110. doi: 10.1039/c7fd00093f.

PMID:
28792036
13.

Age-Related Patterns in Cancer Pain and Its Psychosocial Impact: Investigating the Role of Variability in Physical and Mental Health Quality of Life.

Gauthier LR, Dworkin RH, Warr D, Pillai Riddell R, Macpherson AK, Rodin G, Zimmermann C, Lawrence Librach S, Moore M, Shepherd FA, Gagliese L.

Pain Med. 2018 Apr 1;19(4):658-676. doi: 10.1093/pm/pnx002.

PMID:
28340045
14.

Psychometric Evaluation of the Pain Attitudes Questionnaire-Revised for People With Advanced Cancer.

Mah K, Tran KT, Gauthier LR, Rodin G, Zimmermann C, Warr D, Librach SL, Moore M, Shepherd FA, Gagliese L.

J Pain. 2017 Jul;18(7):811-824. doi: 10.1016/j.jpain.2017.02.432. Epub 2017 Mar 6.

PMID:
28267630
15.

The positive effect of a dedicated adolescent and young adult fertility program on the rates of documentation of therapy-associated infertility risk and fertility preservation options.

Lewin J, Ma JMZ, Mitchell L, Tam S, Puri N, Stephens D, Srikanthan A, Bedard P, Razak A, Crump M, Warr D, Giuliani M, Gupta A.

Support Care Cancer. 2017 Jun;25(6):1915-1922. doi: 10.1007/s00520-017-3597-8. Epub 2017 Feb 2.

PMID:
28155019
16.

2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients.

Roila F, Molassiotis A, Herrstedt J, Aapro M, Gralla RJ, Bruera E, Clark-Snow RA, Dupuis LL, Einhorn LH, Feyer P, Hesketh PJ, Jordan K, Olver I, Rapoport BL, Roscoe J, Ruhlmann CH, Walsh D, Warr D, van der Wetering M; participants of the MASCC/ESMO Consensus Conference Copenhagen 2015.

Ann Oncol. 2016 Sep;27(suppl 5):v119-v133. No abstract available.

PMID:
27664248
17.

Erratum to: 2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapy.

Roila F, Warr D, Hesketh PJ, Gralla R, Herrstedt J, Jordan K, Aapro M, Ballatori E, Rapoport B.

Support Care Cancer. 2017 Jan;25(1):295-296. No abstract available.

PMID:
27624467
18.

2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapy.

Roila F, Warr D, Hesketh PJ, Gralla R, Herrstedt J, Jordan K, Aapro M, Ballatori E, Rapoport B.

Support Care Cancer. 2017 Jan;25(1):289-294. Epub 2016 Aug 11. Erratum in: Support Care Cancer. 2017 Jan;25(1):295-296.

PMID:
27510316
19.

2016 Updated MASCC/ESMO consensus recommendations: Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents.

Jordan K, Chan A, Gralla RJ, Jahn F, Rapoport B, Warr D, Hesketh PJ.

Support Care Cancer. 2017 Jan;25(1):271-275. Epub 2016 Aug 8.

PMID:
27501965
20.

Exploring the mental health benefits of participation in an Australian anti-racism intervention.

Kelaher M, Ferdinand AS, Paradies Y, Warr D.

Health Promot Int. 2018 Feb 1;33(1):107-114. doi: 10.1093/heapro/daw048.

PMID:
27476867
21.

2016 Updated MASCC/ESMO Consensus Recommendations: Prevention of Nausea and Vomiting Following High Emetic Risk Chemotherapy.

Herrstedt J, Roila F, Warr D, Celio L, Navari RM, Hesketh PJ, Chan A, Aapro MS.

Support Care Cancer. 2017 Jan;25(1):277-288. Epub 2016 Jul 22. Review.

PMID:
27443154
22.

ASPIRE: A multi-site community-based participatory research project to increase understanding of the dynamics of violence against immigrant and refugee women in Australia.

Vaughan C, Murdolo A, Murray L, Davis E, Chen J, Block K, Quiazon R, Warr D.

BMC Public Health. 2015 Dec 23;15:1283. doi: 10.1186/s12889-015-2634-0.

23.

Can Patient Risk Factors Outperform Antiemetic Guidelines?: Choosing Wisely.

Warr D, DeAngelis C, Chow E.

JAMA Oncol. 2016 Feb;2(2):232-3. doi: 10.1001/jamaoncol.2015.3757. No abstract available.

PMID:
26561746
24.

Social encounter profiles of greater Melbourne residents, by location--a telephone survey.

Rolls DA, Geard NL, Warr DJ, Nathan PM, Robins GL, Pattison PE, McCaw JM, McVernon J.

BMC Infect Dis. 2015 Nov 2;15:494. doi: 10.1186/s12879-015-1237-9.

25.

Novel fumarate hydratase mutation in a family with atypical uterine leiomyomas and hereditary leiomyomatosis and renal cell cancer.

Wheeler KC, Warr DJ, Warsetsky SI, Barmat LI.

Fertil Steril. 2016 Jan;105(1):144-8. doi: 10.1016/j.fertnstert.2015.09.034. Epub 2015 Oct 19.

PMID:
26493120
26.

Defining the efficacy of neurokinin-1 receptor antagonists in controlling chemotherapy-induced nausea and vomiting in different emetogenic settings-a meta-analysis.

Jordan K, Warr DG, Hinke A, Sun L, Hesketh PJ.

Support Care Cancer. 2016 May;24(5):1941-1954. doi: 10.1007/s00520-015-2990-4. Epub 2015 Oct 17.

PMID:
26476625
27.

Aprepitant and fosaprepitant: a 10-year review of efficacy and safety.

Aapro M, Carides A, Rapoport BL, Schmoll HJ, Zhang L, Warr D.

Oncologist. 2015 Apr;20(4):450-8. doi: 10.1634/theoncologist.2014-0229. Epub 2015 Mar 20. Review.

28.

Randomised, phase II, placebo-controlled, trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone-receptor-positive metastatic breast cancer (MBC): the OCOG ZAMBONEY study.

Clemons MJ, Cochrane B, Pond GR, Califaretti N, Chia SK, Dent RA, Song X, Robidoux A, Parpia S, Warr D, Rayson D, Pritchard KI, Levine MN.

Breast Cancer Res Treat. 2014 Jul;146(1):153-62. doi: 10.1007/s10549-014-3015-6. Epub 2014 Jun 13.

PMID:
24924416
29.

Validation of the short-form McGill pain questionnaire-2 in younger and older people with cancer pain.

Gauthier LR, Young A, Dworkin RH, Rodin G, Zimmermann C, Warr D, Librach SL, Moore M, Shepherd FA, Pillai Riddell R, Macpherson A, Melzack R, Gagliese L.

J Pain. 2014 Jul;15(7):756-70. doi: 10.1016/j.jpain.2014.04.004. Epub 2014 Apr 26.

PMID:
24780200
30.

Efficacy and safety of palonosetron for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV): a systematic review and meta-analysis of randomized controlled trials.

Popovic M, Warr DG, Deangelis C, Tsao M, Chan KK, Poon M, Yip C, Pulenzas N, Lam H, Zhang L, Chow E.

Support Care Cancer. 2014 Jun;22(6):1685-97. doi: 10.1007/s00520-014-2175-6. Epub 2014 Mar 4. Review.

PMID:
24590374
31.

Prognostic factors for chemotherapy induced nausea and vomiting.

Warr D.

Eur J Pharmacol. 2014 Jan 5;722:192-6. doi: 10.1016/j.ejphar.2013.10.015. Epub 2013 Oct 21. Review.

PMID:
24157977
32.

Working better together: new approaches for understanding the value and challenges of organizational partnerships.

Riggs E, Block K, Warr D, Gibbs L.

Health Promot Int. 2014 Dec;29(4):780-93. doi: 10.1093/heapro/dat022. Epub 2013 Apr 28.

PMID:
23630133
33.

The communal coping model and cancer pain: the roles of catastrophizing and attachment style.

Gauthier LR, Rodin G, Zimmermann C, Warr D, Librach SL, Moore M, Shepherd FA, Gagliese L.

J Pain. 2012 Dec;13(12):1258-68. doi: 10.1016/j.jpain.2012.10.001.

PMID:
23182231
34.

A randomized double-blind placebo-controlled cross-over trial of the impact on quality of life of continuing dexamethasone beyond 24 h following adjuvant chemotherapy for breast cancer.

Vardy J, Pond G, Dodd A, Warr D, Seruga B, Clemons M, Bordeleau L, Goodwin P, Tannock IF.

Breast Cancer Res Treat. 2012 Nov;136(1):143-51. doi: 10.1007/s10549-012-2205-3. Epub 2012 Sep 6.

PMID:
22956006
35.

Management of highly emetogenic chemotherapy.

Warr D.

Curr Opin Oncol. 2012 Jul;24(4):371-5. doi: 10.1097/CCO.0b013e328352f6fb. Review.

PMID:
22476193
36.

Delayed emesis: moderately emetogenic chemotherapy (single-day chemotherapy regimens only).

Roila F, Warr D, Aapro M, Clark-Snow RA, Einhorn L, Gralla RJ, Herrstedt J, Saito M, Tonato M.

Support Care Cancer. 2011 Mar;19 Suppl 1:S57-62. doi: 10.1007/s00520-010-1039-y. Epub 2010 Dec 5.

PMID:
21132332
37.

Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors.

Bordeleau L, Pritchard KI, Loprinzi CL, Ennis M, Jugovic O, Warr D, Haq R, Goodwin PJ.

J Clin Oncol. 2010 Dec 10;28(35):5147-52. doi: 10.1200/JCO.2010.29.9230. Epub 2010 Nov 8.

PMID:
21060031
38.

Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity--state of the art.

Grunberg SM, Warr D, Gralla RJ, Rapoport BL, Hesketh PJ, Jordan K, Espersen BT.

Support Care Cancer. 2011 Mar;19 Suppl 1:S43-7. doi: 10.1007/s00520-010-1003-x. Epub 2010 Oct 24. Review.

PMID:
20972805
39.

Acute emesis: moderately emetogenic chemotherapy.

Herrstedt J, Rapoport B, Warr D, Roila F, Bria E, Rittenberg C, Hesketh PJ.

Support Care Cancer. 2011 Mar;19 Suppl 1:S15-23. doi: 10.1007/s00520-010-0951-5. Epub 2010 Aug 2.

PMID:
20680356
40.

Differential time course of action of 5-HT3 and NK1 receptor antagonists when used with highly and moderately emetogenic chemotherapy (HEC and MEC).

Hesketh PJ, Warr DG, Street JC, Carides AD.

Support Care Cancer. 2011 Sep;19(9):1297-302. doi: 10.1007/s00520-010-0944-4. Epub 2010 Jul 11.

PMID:
20623144
41.

Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference.

Roila F, Herrstedt J, Aapro M, Gralla RJ, Einhorn LH, Ballatori E, Bria E, Clark-Snow RA, Espersen BT, Feyer P, Grunberg SM, Hesketh PJ, Jordan K, Kris MG, Maranzano E, Molassiotis A, Morrow G, Olver I, Rapoport BL, Rittenberg C, Saito M, Tonato M, Warr D; ESMO/MASCC Guidelines Working Group.

Ann Oncol. 2010 May;21 Suppl 5:v232-43. doi: 10.1093/annonc/mdq194. Review. No abstract available.

PMID:
20555089
42.

Evaluating health impacts: Results from the neighbourhood renewal strategy [corrected] in Victoria, Australia.

Kelaher M, Warr DJ, Tacticos T.

Health Place. 2010 Sep;16(5):861-7. doi: 10.1016/j.healthplace.2010.04.011. Epub 2010 Apr 28. Erratum in: Health Place. 2011 Nov;17(6):1297.

PMID:
20472489
43.
44.

Living in 'Birdsville': exploring the impact of neighbourhood stigma on health.

Kelaher M, Warr DJ, Feldman P, Tacticos T.

Health Place. 2010 Mar;16(2):381-8. doi: 10.1016/j.healthplace.2009.11.010. Epub 2009 Nov 26.

PMID:
20031473
45.

Was it good for you too? Impediments to conducting university-based collaborative research with communities experiencing disadvantage.

MacLean S, Warr D, Pyett P.

Aust N Z J Public Health. 2009 Oct;33(5):407-12. doi: 10.1111/j.1753-6405.2009.00420.x.

PMID:
19811474
46.

Age-related patterns in adaptation to cancer pain: a mixed-method study.

Gagliese L, Jovellanos M, Zimmermann C, Shobbrook C, Warr D, Rodin G.

Pain Med. 2009 Sep;10(6):1050-61. doi: 10.1111/j.1526-4637.2009.00649.x. Epub 2009 Jul 6.

PMID:
19594849
47.

Challenging roles: insights into issues for men caring for family members with mental illness.

Fraser C, Warr DJ.

Am J Mens Health. 2009 Mar;3(1):36-49. doi: 10.1177/1557988307311353. Epub 2008 Jun 6.

PMID:
19477718
48.

Acceptance of pain: a study in patients with advanced cancer.

Gauthier LR, Rodin G, Zimmermann C, Warr D, Moore M, Shepherd F, Gagliese L.

Pain. 2009 May;143(1-2):147-54. doi: 10.1016/j.pain.2009.02.009. Epub 2009 Mar 25.

PMID:
19321264
49.

Sources of stress in impoverished neighbourhoods: insights into links between neighbourhood environments and health.

Warr D, Feldman P, Tacticos T, Kelaher M.

Aust N Z J Public Health. 2009 Feb;33(1):25-33. doi: 10.1111/j.1753-6405.2009.00334.x.

PMID:
19236355
50.

People, places and policies - trying to account for health inequalities in impoverished neighbourhoods.

Feldman P, Warr D, Tacticos T, Kelaher M.

Aust N Z J Public Health. 2009 Feb;33(1):17-24. doi: 10.1111/j.1753-6405.2009.00333.x.

PMID:
19236354

Supplemental Content

Support Center